Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.22M | 2.78M | 3.47M | 2.70M | 2.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.22M | 2.78M | 3.47M | 2.70M | 2.87M |
| Cost of Revenue | 1.65M | 1.57M | 2.00M | 1.58M | 1.61M |
| Gross Profit | 1.57M | 1.21M | 1.47M | 1.12M | 1.26M |
| SG&A Expenses | 1.16M | 1.10M | 1.16M | 1.12M | 1.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.96M | 2.81M | 3.33M | 2.85M | 2.94M |
| Operating Income | 255.90K | -27.00K | 138.30K | -156.60K | -70.50K |
| Income Before Tax | 246.00K | -32.20K | 134.40K | -162.10K | -76.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 246.00K | -32.20K | 134.40K | -162.10K | -76.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 246.00K | -32.20K | 134.40K | -162.10K | -76.30K |
| EBIT | 255.90K | -27.00K | 138.30K | -156.60K | -70.50K |
| EBITDA | 265.80K | -16.30K | 157.60K | -153.00K | -58.40K |
| EPS Basic | 0.02 | -0.01 | 0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.02 | 0.00 | 0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.02 | -0.01 | 0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M |
| Average Diluted Shares Outstanding | 14.08M | 7.42M | 7.42M | 7.42M | 7.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
